
Moderna kicks off bird flu mRNA vaccine trial as funding dries up
Moderna is launching a large-scale human trial of an mRNA vaccine for H5N1 bird flu after the Department of Health and Human Services canceled hundreds of millions in funding for vaccine development, signaling a shift in U.S. pandemic preparedness.













